Asuman Demirbuğa

Dr. Asuman Demirbuğa

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Microvascular Research
Verified
Journal Article
Closed access
FÇFigen Çakmak
Figen Çakmak
ADAsuman Demirbuğa
Asuman Demirbuğa
DDDemet Demirkol
Demet Demirkol
SGSüheyla Gümüş
Süheyla Gümüş
STSelda Hançerli Törün
Selda Hançerli Törün
NANuray Aktay Ayaz
Nuray Aktay Ayaz

11 February 2019 in Indian Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
GSGuntulu Sık
Guntulu Sık
ADAsuman Demirbuğa
Asuman Demirbuğa
SGSeda Günhar
Seda Günhar
KNKemal Nisli
Kemal Nisli
AÇAgop Çıtak
Agop Çıtak

20 October 2023 in Pediatrics & Neonatology
Verified
Journal Article
Open access
ADAsuman Demirbuğa
Asuman Demirbuğa
BKBahar Akgün Karapınar
Bahar Akgün Karapınar
BYBeril Yaşa
Beril Yaşa
AÇAsuman Çoban
Asuman Çoban
BÖBetigül Öngen
Betigül Öngen
STSelda Hançerli Törün
Selda Hançerli Törün
Objective: Stenotrophomonas maltophilia is an emerging multi-drug resistant, opportunistic pathogen in the neonatal intensive care unit (NICU). In this study, we aimed to assess the incidence, clinical features, antibiotic susceptibility, and treatment options of S. maltophilia infection among the healthcare-associated infections (HAIs) in the neonatal unit. Methods: In this study , the patients who were hospitalized in the NICU between January 2020 and December 2021 with S. maltophilia isolated from clinical samples were included. Demographic, clinic features, and microbiological findings of the patients were retrospectively evaluated by using the medical records. The samples (lower respiratory tract, urine, peritoneal fluid) were first examined microscopically by gram preparation and cultured. Antibiotic susceptibility tests were performed according to the recommendations of The European Committee on Antimicrobial Susceptibility Testing (EUCAST) for TMP-SMX. Results: S. maltophilia was isolated in 38 clinical samples of the 20 patients who were hospitalized at the NICU between January 2020 and December 2021. A total of 40 % (n = 8) of samples from different patients were accepted as colonization. Ventilator-associated pneumonia was determined in 55 % (n = 11), and urinary tract infection in 5 % (n = 1). S. maltophilia -associated bacteremia was not detected in any of the cases. The TMP-SMX susceptibilities of the strains were as it follows: 3 (15 %) were resistant (R), 7 (28 %) were susceptible (S), and 10 (47 %) were susceptible-increased exposure (I). Three of these patients were given dual antibiotics therapy (levofloxacin plus TMP-SMX) and nine of them were given only TMP-SMX. The most common hospital-acquired infectious agents are Gram negative microorganisms (51 %), followed by coagulase negative staphylococci (CNS), Staphylococcus aureus (24 %) and S. maltophilia (24 %). Conclusion: Increasing TMP-SMX resistance and specific drug and dosage-related problems in the neonatal unit are important problems in treatment management.

27 September 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
POPembe Derin Oygar
Pembe Derin Oygar
ABAyşe Büyükçam
Ayşe Büyükçam
ZBZümrüt Şahbudak Bal
Zümrüt Şahbudak Bal
NDNazan Dalgıç
Nazan Dalgıç
ŞBŞefika Elmas Bozdemir
Şefika Elmas Bozdemir
AKAteş Kara
Ateş Kara
Understanding SARS-CoV-2 seroprevalence among health care personnel is important to explore risk factors for transmission, develop elimination strategies and form a view on the necessity and frequency of surveillance in the future. We enrolled 4927 health care personnel working in pediatric units at 32 hospitals from 7 different regions of Turkey in a study to determine SARS Co-V-2 seroprevalence after the first peak of the COVID-19 pandemic. A point of care serologic lateral flow rapid test kit for immunoglobulin (Ig)M/IgG was used. Seroprevalence and its association with demographic characteristics and possible risk factors were analyzed. SARS-CoV-2 seropositivity prevalence in health care personnel tested was 6.1%. Seropositivity was more common among those who did not universally wear protective masks (10.6% vs 6.1%). Having a COVID-19-positive co-worker increased the likelihood of infection. The least and the most experienced personnel were more likely to be infected. Most of the seropositive health care personnel (68.0%) did not suspect that they had previously had COVID-19. Health surveillance for health care personnel involving routine point-of-care nucleic acid testing and monitoring personal protective equipment adherence are suggested as important strategies to protect health care personnel from COVID-19 and reduce nosocomial SARS-CoV-2 transmission.

8 September 2021 in Pediatric Allergy, Immunology, and Pulmonology
Verified
Journal Article
Closed access
ADAsuman Demirbuğa
Asuman Demirbuğa
OKOzge Kaba
Ozge Kaba
STSelda Hançerli Törün
Selda Hançerli Törün
EYEdibe Pembegül Yıldız
Edibe Pembegül Yıldız
EYEsra Yücel
Esra Yücel
ASAyper Somer
Ayper Somer
Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease of the central nervous system that is caused by John Cunningham virus (JCV). It occurs almost exclusively in immunosuppressed individuals, for example, patients with AIDS and hematological and lymphoreticular malignancies. In this article, we present a review of the literature and 2 case reports with PML. The first report examines a 15-year-old male (who presented with dedicator of cytokinesis 8 deficiency) who was diagnosed as having PML based on characteristic magnetic resonance imaging (MRI) lesions and a positive PCR for JCV in cerebrospinal fluid. He was transferred for bone marrow transplantation after stabilization with therapy of maraviroc and cidofovir. The second report examines a 6-year-old male who presented with encephalitis and was also diagnosed with AIDS. He was diagnosed with PML and started treatment with cidofovir. His clinical status and MRI findings deteriorated rapidly. In immunosuppressive patients who developed encephalopathy, JCV ought to be considered.

1 September 2025 in The Turkish Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
ÖŞÖzlem Şensoy
Özlem Şensoy
Ayfer AydınAyfer Aydın
Ayfer Aydın
SBSema Bayraktar
Sema Bayraktar
ASAyper Somer
Ayper Somer
ADAsuman Demirbuğa
Asuman Demirbuğa
STSelda Hançerli Törün
Selda Hançerli Törün
Aim. This study aimed to describe barriers and facilitators of the adherence of children with human immunodeficiency virus (HIV) to antiretroviral therapy (ART) from the perspectives of their caregivers. Methods. In-depth interviews were held with the caregivers of 15 children. The collected data were analyzed using thematic analysis procedures. The Consolidated Criteria for Reporting Qualitative Research (COREQ) were followed in the study. Results. The perspectives of caregivers were categorized under four themes and subthemes. Barriers and facilitators of the adherence of children with HIV to ART were categorized into 4 main themes: (1) medication-related, (2) child-related, (3) caregiver-related, and (4) health system-related. The results indicated that understanding the factors that influence pediatric ART adherence is critical to the development of adequate strategies. In addition, disclosure of HIV status to the child is also an important factor affecting drug administration in the social environment. Conclusions. To ensure adherence to lifelong ART, targeted caregiver support through continuous supervision, clear guidance on drug preparation, and strategies for effective administration should be integrated into context-specific interventions that address the combined influence of factors related to the child, medication, healthcare, and of the sociocultural environment.